AWS for Industries

Category: Life Sciences

Improving AstraZeneca Japan’s Enterprise Search Capabilities and Regulatory Compliance using Amazon Kendra

Ethical marketing compliance is critically important for pharmaceutical companies operating in Japan to prevent the miscommunication of wrong or outdated information. In a country known for its strict regulations and emphasis on consumer protection, these companies must adhere to a set of ethical guidelines to maintain trust and make sure of the well-being of patients. […]

Amazon HealthLake ChatBot image

Interact Conversationally with AWS HealthLake

Large language models (LLMs) are revolutionizing the way we interact with technology, and AWS HealthLake is no exception. HealthLake is a secure, HIPAA-eligible data lake that allows healthcare organizations to store, transform, and analyze their health data at scale. By combining HealthLake with an LLM, healthcare providers can interact conversationally with their data, gaining insights and making decisions […]

Data and Analytics environments at Merck KGaA, Darmstadt, Germany using AWS Services

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare, and electronics. More than 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing, well […]

Executive Conversations: Using the cloud to develop accessible, interoperable healthcare data for cancer and beyond

Whether advancing evidence-based policy, value-based healthcare, or community wellness, access to longitudinal health data is a force multiplier for progress. Dr. Jay Schnitzer, Chief Technology Officer (CTO) and Chief Medical Officer (CMO) at MITRE, recently sat down with Valerie Delva, Worldwide Head, Data/AI ML Strategy and Solutions at Amazon Web Services (AWS) to discuss the […]

Executive Conversations: The promise of generative AI for the commercial pharma value chain

Merck & Co., Inc., Rahway, NJ, USA, one of the largest pharmaceutical companies in the world, has been using generative artificial intelligence (generative AI) to push the borders of data science and analytics in life sciences. Harish Nankani, Associate Vice President, Data and Analytics, Merck, and Suman Giri, Executive Director, Data Science, Merck, recently spoke […]

Bio-Rad utilizes AWS Systems Manager to construct an IoT device, empowering their Next Generation Quality Control Informatics Solution

This blog is guest-authored by Jasmina Desai, Associate Director, Software Architecture at Bio-Rad Laboratories, Inc. — The key to success for clinical diagnostics labs is a precise and accurate result with every run. As a trusted provider, Bio-Rad Laboratories (Bio-Rad) offers independent quality control products that help streamline workflows, reduce errors, maintain compliance, and facilitate […]

Executive Conversations with Nosis Bio and Vevo: Using Generative AI on AWS to Shift the Pharmaceutical R&D Paradigm

Today, organizations are looking to harness the power of generative AI, including foundation models (FMs) and large language models (LLMs) to innovate faster to reinvent patient outcomes. While this has created a lot of hype, the adoption of these technologies in real-world drug development is still a challenge for most organizations. Amrita Sarkar, Principal Healthcare […]

Coriell Life Sciences Uses the Cloud for Medication Decision Support

Coriell Life Sciences uses the AWS Cloud to provide patients, physicians, and pharmacists insight into the safest, most effective medications based on an individual’s DNA and other factors. More than 131 million people—66% of all adults in the United States—use prescription medicines to manage health conditions, according to Georgetown’s Health Policy Institute. Utilization is highest […]

How AWS can help you adapt to new regulatory draft guidance for use of learning AI in medical devices

New draft guidance from the Food and Drug Administration (FDA) opens the door for medical devices with AI/ML to learn and improve after the product comes to market. The guidance, required by Congress in late 2022 as part of the fiscal year 2023 omnibus bill, addresses a long-standing challenge with the approval or clearance of […]

Executive Conversations: Building the Brain Knowledge Platform, with Shoaib Mufti, Data and Technology Lead at the Allen Institute for Brain Science

Shoaib Mufti, Head of Data and Technology at the Allen Institute for Brain Science, joins Lisa McFerrin, Worldwide Lead for Research, Discovery, and Translational Medicine at Amazon Web Services (AWS), to share how the Allen Institute is using the cloud to build the Brain Knowledge Platform (BKP) for the U.S. National Institutes of Health (NIH) […]